The prognostic value of longitudinal circulating tumor DNA profiling during osimertinib treatment

BACKGROUND: Serial profiling of circulating tumor DNA (ctDNA) could reflect dynamic molecular changes in response to treatment and potentially predict impending disease progression (PD). Herein, we investigated the molecular factors and dynamic changes in ctDNA that can serve as predictors of surviv...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Shenglin, Shi, Meiqi, Chen, Xueqin, Wang, Yong, Yang, Zhenhua, Lizaso, Analyn, Li, Min, Li, Haiyan, Zhang, Lu, Mao, Xinru, Xu, Xingxiang, Song, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867761/
https://www.ncbi.nlm.nih.gov/pubmed/33569316
http://dx.doi.org/10.21037/tlcr-20-371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867761/
https://www.ncbi.nlm.nih.gov/pubmed/33569316
http://dx.doi.org/10.21037/tlcr-20-371

Ejemplares similares